Gonorrhoea risks becoming ‘untreatable' amid rising antibiotic-resistant cases
Cases of gonorrhoea infections that are resistant to antibiotics are on the rise in England, officials have warned.
If not tackled, increased resistance could one day make the sexually transmitted infection (STI) 'untreatable'.
Gonorrhoea can usually be treated effectively, although some cases can be resistant to the antibiotic ceftriaxone, which is the first line of treatment.
This means the bacteria that causes the infection has developed the ability to survive and multiply even when exposed to the antibiotic.
Some cases are also classed as 'extensively drug resistant' – or XDR – meaning the infection did not respond to ceftriaxone or the second line of treatment.
New figures from the UK Health Security Agency (UKHSA) show that in the 15 months from January 2024 to March 2025, there were 17 cases of ceftriaxone-resistant gonorrhoea.
Thirteen were reported in 2024, with four cases in 2025 so far.
This is compared to 16 cases across 2022 and 2023.
In the same period, there were nine XDR cases reported – six in 2024 and three in 2025 so far.
This is compared to five cases between 2022 and 2023.
Ceftriaxone-resistant gonorrhoea was first detected in England in 2015 and 42 cases have since been reported.
Most cases are linked to the Asia-Pacific region, were resistance to ceftriaxone is common, according to the UKHSA.
Transmission in England is so far limited, but rising cases could present treatment challenges in the future.
Symptoms of gonorrhoea include green or yellow discharge from the vagina or penis, pain when urinating, pain and discomfort in the rectum.
For women, symptoms can include lower abdominal pain or bleeding between periods.
However, many people do not have symptoms.
Dr Katy Sinka, consultant epidemiologist and head of the STI section at UKHSA, said: 'Gonorrhoea is becoming increasingly resistant to antibiotics, which could make it untreatable in future.
'If left untreated, it can cause serious problems like pelvic inflammatory disease and infertility.'
Neisseria gonorrhoeae, the bacteria that causes gonorrhoea, appears on the UKHSA's list of viruses and bacteria which pose the greatest threat to public health.
Figures from the agency show there were about 54,965 gonorrhoea diagnoses at sexual health services in the first nine months of 2024 compared to more than 85,000 in the whole of 2023.
There were also about 7,000 syphilis cases in the first nine months of last year compared to 9,513 in the whole of 2023.
Dr Sinka added: 'The best way to stop STIs is by using a condom.
'If you've had condomless sex with a new or casual partner, get tested, whatever your age, gender or sexual orientation. This includes when you are having sex abroad.
'Early detection not only protects your health but prevents transmission to others. Many STIs show no symptoms, which is why regular testing is so important.
'Testing is quick, free and confidential.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
2 days ago
- Los Angeles Times
Pelvic Inflammatory Disease: Diagnosis and Treatment Strategies
Pelvic Inflammatory Disease (PID) is a sneaky infection that affects the upper female reproductive tract – uterus, fallopian tubes and ovaries – and is classified as an upper genital tract infection. Often linked to untreated sexually transmitted infections (STIs), most cases of PID are caused by sexually transmitted bacteria. PID can have serious reproductive consequences such as chronic pelvic pain, ectopic pregnancy and infertility. If left untreated PID can cause permanent damage to reproductive organs which can impact fertility and overall reproductive health. The challenge for clinicians is not only the subtle or non specific symptoms but also the expanding list of causative pathogens and shifting resistance patterns. Risk factors for PID are unprotected sex and having multiple partners which increases the risk of PID especially in young women. Fortunately recent research is changing how we approach diagnosis, treatment and prevention – offering hope for better outcomes with early comprehensive care. Diagnosing a PID isn't as simple as ordering one test. Most clinicians rely on a combination of clinical signs: lower abdominal pain, cervical motion tenderness and uterine or adnexal tenderness. Clinical diagnosis is key with pelvic examination playing a big role in evaluating cervical discharge, uterine tenderness and lower genital tract inflammation. The classic 2008 study on PID management advises to have a 'low threshold' for diagnosis especially since delayed treatment can cause permanent reproductive damage [1]. Early diagnosis is essential to prevent complications and long term sequelae. But the microbial picture is more complicated than that. While Chlamydia trachomatis and Neisseria gonorrhoeae are still the well known culprits, they're not the only ones. A 2021 review in The Journal of Infectious Diseases points to pathogens like Mycoplasma genitalium as emerging players in PID [7]. These atypical bacteria often evade traditional STI tests making diagnosis harder and highlighting the need for broader microbial screening. Subclinical PID often resulting from less symptomatic infections like chlamydia can still cause long term consequences even in the absence of symptoms. Another 2021 study 'Etiology and Diagnosis of Pelvic Inflammatory Disease' goes even further by suggesting diagnostic strategies that go beyond gonorrhea and chlamydia [8]. This broader approach reduces misdiagnosis and ensures treatment addresses the full range of potential infections – a key to better long term outcomes. When evaluating severe pain in the pelvic region or lower abdomen, clinicians must consider alternative diagnoses like ovarian torsion and tubo ovarian abscess. Diagnostic tools may include pelvic ultrasound and in uncertain cases endometrial biopsy to clarify the diagnosis. Comprehensive evaluation is key and clinicians must diagnose PID accurately to avoid missing cases with atypical presentations. When PID is suspected the standard advice is to treat immediately before test results confirm a specific pathogen. That's because empiric therapy which uses broad spectrum antibiotics covers the wide range of bacteria associated with PID. Empiric treatment and prompt treatment is crucial to prevent complications like chronic pelvic pain, infertility and ectopic pregnancy. The 2019 American Family Physician review outlines best practices for outpatient and inpatient settings and emphasizes early treatment especially in high risk women [2]. Outpatient treatment is an option for most patients with mild to moderate symptoms and allows them to manage the infection without hospitalization. Emergency medicine literature reinforces this point. Studies in Emergency Medicine Practice (2016 and 2022) stress the importance of prompt intervention especially in emergency departments where many PID cases present first [5] [6]. These papers also emphasize clear discharge instructions and the need for close follow up especially for women whose symptoms don't resolve fully within the first few days. It's essential to treat PID promptly and make sure patients receive treatment to avoid long term complications from pelvic infection. Choosing the right antibiotic combination matters too. A 2013 BMJ review using GRADE scoring to assess evidence strength suggests regimens with doxycycline, cefoxitin or ceftriaxone and metronidazole are most effective [9]. The same review also highlights the benefit of prophylactic antibiotics before IUD insertion especially in high risk patients. Birth control methods like IUDs can increase the risk of pelvic infection especially in the presence of bacterial vaginosis which disrupts the vaginal flora and may contribute to ascending infections. While most PID can be managed with outpatient antibiotics some scenarios require more intensive management. Hospitalization is recommended for patients who are pregnant, have severe symptoms, have an abscess or aren't responding to oral medications. Infections of the upper female genital tract and pelvic organs can cause long term complications including damage to the reproductive organs like the uterus, fallopian tubes and ovaries. A 2023 article in Therapeutics and Clinical Risk Management advises clinicians to stratify care based on illness severity and risk factors [3]. This includes considering polymicrobial infections and resistance trends when choosing treatment regimens. Presence of anaerobes or treatment resistant bacteria may require intravenous antibiotics or surgical intervention. There is also potential for scar tissue formation in the fallopian tube and other reproductive organs which can cause chronic pain and infertility. A 2010 review in Obstetrics and Gynecology echoes this message. It states most women recover well with outpatient care but clinicians must be aware of microbial diversity especially in populations where STI prevalence is high or access to care is limited [4]. As our understanding of PID evolves so do the tools to diagnose and treat it. Traditional STI panels may miss important pathogens which is why there's growing interest in non-invasive tests and molecular diagnostics. These technologies including nucleic acid amplification tests (NAATs) can detect low abundance microbes like Mycoplasma genitalium that traditional methods miss [3] [7]. Looking ahead experts recommend a multipronged approach: Some public health campaigns are already incorporating these principles. For example the CDC's updated STI guidelines now include emerging pathogens and detailed follow up protocols. Planned Parenthood's PID awareness campaign stresses education, partner treatment and timely care – all key to stopping the cycle of reinfection. Comprehensive testing for other STIs like HIV and syphilis is also recommended for sexually active individuals. When discussing partner notification and public health education all sexual partners should be treated and advised to abstain from sexual intercourse or sexual contact until treatment is complete to prevent reinfection and further spread among sexually active individuals. Pelvic Inflammatory Disease is one of the most common and most misunderstood gynecological emergencies. The infection's polymicrobial nature, subtle presentation and potential for long term harm make it a unique challenge in women's health. But the tide is turning. With growing awareness, better diagnostic tools and research based treatment strategies there is a clear path forward. Clinicians must stay up to date with evolving recommendations especially as we discover new pathogens and confront antibiotic resistance. The goal is no longer just treatment – it's prevention, precision and protecting reproductive futures. [1] Haggerty, C. L., & Ness, R. B. (2008). Diagnosis and treatment of pelvic inflammatory disease. Women's health (London, England), 4(4), 383–397. [2] Curry, A., Williams, T., & Penny, M. L. (2019). Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. American family physician, 100(6), 357–364. [3] Yusuf, H., & Trent, M. (2023). Management of Pelvic Inflammatory Disease in Clinical Practice. Therapeutics and clinical risk management, 19, 183–192. [4] Soper D. E. (2010). Pelvic inflammatory disease. Obstetrics and gynecology, 116(2 Pt 1), 419–428. [5] Bugg, C. W., & Taira, T. (2016). Pelvic Inflammatory Disease: Diagnosis And Treatment In The Emergency Department. Emergency medicine practice, 18(12), 1–24. [6] Taira, T., Broussard, N., & Bugg, C. (2022). Pelvic inflammatory disease: diagnosis and treatment in the emergency department. Emergency medicine practice, 24(12), 1–24. [7] Hillier, S. L., Bernstein, K. T., & Aral, S. (2021). A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease. The Journal of infectious diseases, 224(12 Suppl 2), S23–S28. [8] Mitchell, C. M., Anyalechi, G. E., Cohen, C. R., Haggerty, C. L., Manhart, L. E., & Hillier, S. L. (2021). Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia. The Journal of infectious diseases, 224(12 Suppl 2), S29–S35. [9] Ross J. D. (2013). Pelvic inflammatory disease. BMJ clinical evidence, 2013, 1606.
Yahoo
3 days ago
- Yahoo
Heat health alert issued in Sussex for first time this year
A heat health warning has been issued by the UK Health Security Agency (UKHSA). A yellow heat-health alert was issued today for the South East, which covers all of Sussex. The alert is in effect from June 12 at 9:00pm to June 15 at 8:00am. It is the first time in 2025 that heat-health warnings have been issued by UKHSA. UKHSA said: "Minor impacts are likely across health and social services. "These include: increased use of healthcare services by vulnerable people; greater risk to life of vulnerable people; increased potential for indoor environments to become very warm." The weather health alerting system is provided by UKHSA in partnership with the Met Office. It's intended to provide early warning to the health and social care sector, the responder community, the voluntary and community sector, and government departments when adverse temperatures are likely to impact the health and wellbeing of the population. People are likely to flock to Brighton beach this weekend (Image: Sussex News and Pictures) The weather health alerting system is made up of the Heat-Health Alerts (HHA) and Cold-Health Alerts (CHA). The weather health alerting system underpins the Adverse Weather and Health Plan. The heat health alert comes on the back of the Met Office issuing a yellow weather warning due to the possibility of thunderstorms across the South East, including all of Sussex. READ NEXT: The Sussex businesses named and shamed for failing to pay minimum wage The warning from the Met Office is in place for the East and South East of England, from 3:00 pm on Friday (June 13) to 6:00 am on Saturday (June 14). The Met Office warns that thunderstorms may bring "some disruption" across the region, with a chance of "torrential" rain and lightning. There is also potential for power cuts and flooding. The Met Office is currently forecasting temperatures of up to 24 degrees in Brighton on Friday.
Yahoo
3 days ago
- Yahoo
Do you have a summer cold or is it the new strain of Covid?
We associate colds and viruses with the winter, and for good reason. Illness spikes in the colder months because it's a time when we huddle indoors, creating the perfect environment for viruses to spread. Then there's the cold air, which dries out our airways and leaves us more vulnerable to catching bugs. Why then are we still getting colds in the summer? The culprits: there are still bugs that can make you sniffily at this time of year, and there's also a new Covid strain beginning to spread in Britain. So, which could be making you unwell and, most importantly, what can you do to avoid it? The NB.1.8.1 Covid strain is the latest that health officials are keeping their eyes on. It first emerged in China in January and the World Health Organization (WHO) began tracking it a fortnight ago because of some potentially worrying mutations that the variant carries. 'There is some early indication that it may be slightly better at evading immune responses and antibodies, but this is very early data,' explains Dr Lindsay Broadbent, assistant professor in virology at the University of Surrey. However, the risk posed by NB.1.8.1 remains low, and there is no evidence that it causes a more severe illness or is drastically different to previous strains of the virus, she notes. 'People don't need to be overly concerned,' Dr Broadbent adds. Latest weekly data from the UK Health Security Agency (UKHSA) suggests there's been a slight uptick in Covid infections in recent weeks. Of patients tested by their GP, 5.2 per cent tested positive for Covid, up from 4.5 per cent the week before. Since first being detected in the UK in January there have been 13 confirmed cases of NB.1.8.1, though 12 of these were recorded in April and May. For context, around 50 positive tests are currently being sequenced per week. This is when a throat or nose sample that tested positive for Covid is genetically sequenced to determine the variant behind the infection. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid cases,' notes Dr Gayatri Amirthalingam, deputy director of the UKHSA. 'Based on the available information so far, however, there is no evidence to suggest that this variant causes more severe disease than previous variants, or that the vaccines in current use will be less effective against it.' While there is typically a cyclical spike in colds in the winter, that doesn't mean they disappear in the warmer months. In fact, some cold-causing viruses, such as parainfluenza virus Type 3 and enteroviruses (especially coxsackieviruses and echoviruses) are much more common in the summer, says Prof Fidelma Fitzpatrick, head of clinical microbiology at the Royal College of Surgeons in Ireland, and consultant microbiologist in Beaumont Hospital in Dublin. Summer colds can also be caused by adenoviruses, which spread year-round but can have peaks in the summer, and rhinoviruses, which is the classic winter cold but is still around in the summer, she says. 'The risk of being exposed to a virus and getting sick depends on lots of factors including our behaviour, the environment and how common those viruses are at any given time,' Dr Broadbent explains. As we enter the summer, people's social calendars tend to fill up with weddings, parties, festivals and holidays, meaning lots of mixing between different groups and generations that wouldn't be together otherwise, says Prof Fitzpatrick. 'There is often more socialising and travel during the summer months, this may mean we are in contact with a lot more people than usual,' Dr Broadbent confirms. Adding to that is that activities that often come with summer festivities – alcohol, a lack of sleep and eating more processed foods – are known to weaken our immune system, making us less equipped to fight off these cold-causing bugs, Prof Fitzpatrick says. Additionally, air conditioning can dry out our nasal passages, which makes it easier for viruses to infect, she notes. It's unclear whether summer colds are on the rise, as the specific viruses that cause them are not tracked. Latest UKHSA data suggests that parainfluenza cases decreased slightly in the week to June 1, though this reflects the trend for all four types of parainfluenza and only Type 3 is specifically linked with summer colds. Covid continues to cause cold-like symptoms for most people. 'Most infected people have mild to moderate symptoms,' says Prof Fitzpatrick. These include a runny nose, sore throat, congestion, a mild cough, tiredness and headaches. However, people with underlying health conditions face a higher risk of developing more serious symptoms, such as difficulty breathing, and the illness lasting for longer. It's impossible to know from the symptoms alone whether you have Covid or a summer cold, as the latter also causes a runny nose, low energy, muscle aches, a cough, headache and sore throat, Prof Fitzpatrick says. However, Covid tests are available from pharmacies with prices starting around £2, which can indicate if that virus is to blame. While there are no Covid restrictions in place, official advice recommends trying to stay at home if you catch the virus. Short of isolating yourself at home, there's unfortunately no magic bullet that will guarantee that you won't catch a virus this summer. 'Tips for avoiding summer colds are the same advice as any time of the year,' says Dr Broadbent. 'Try to maintain good hand and respiratory hygiene, including washing your hands and using tissues,' she says. Prof Fitzpatrick recommends staying hydrated and avoiding excess alcohol, which can dehydrate you and impair your immunity, as well as using sanitising wipes on aeroplane trays, gym equipment and other communal surfaces. Supporting your immune system by sleeping well, eating a varied diet rich in fruits, vegetables and lean protein and watching your stress levels can all help to reduce the risk of catching a bug in the first place, she says. Other ways to stave off a cold include drinking lots of fluids and making sure you are topped up on vitamin D, which supports a healthy immune system. 'If you do get a summer cold, it is best to avoid close contact with anyone that may be more at risk of severe disease, such as babies and young children, older adults and people that have underlying conditions like lung disease or heart disease,' Dr Broadbent adds. Most people recover from a Covid infections and summer colds at home with a combination of rest, staying hydrated and taking over-the-counter medications, such as paracetamol, to manage symptoms like a fever, headache and muscle aches, Prof Fitzpatrick says. Decongestants can also be helpful to reduce nasal congestion, while lozenges can ease a sore throat, she notes. Antibiotics won't help with recovery from a Covid infection or cold, as 'there is no role for antibiotics' in viral infections, she explains. 'If a person's symptoms get worse, however, and they develop trouble breathing, they should contact their doctor for advice,' Prof Fitzpatrick says. Chest pain and confusion are also signs that a patient should seek medical help. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
